Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess whether quadratus lumborum (QL) block performed 1 day after cesarean delivery will provide supplemental post-cesarean analgesia and reduce opioid requirements.
Age
18 - 50 years
Sex
FEMALE
Healthy Volunteers
No
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Start Date
January 1, 2022
Primary Completion Date
June 30, 2022
Completion Date
June 30, 2022
Last Updated
November 3, 2023
Saline
DRUG
Bupivacaine
DRUG
Dexamethasone
DRUG
Lead Sponsor
The University of Texas Health Science Center, Houston
NCT07396753
NCT06275191
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions